
Nextleaf Solutions Ltd. (OTCQB:OILFF) (CSE:OILS) (FSE:L0MA) provided an update on its specialty molecules division, specifically the company's patented novel route of manufacturing D9-tetrahydrocannabinol acetate, colloquially referred to as THC-O.
Nextleaf has recently produced THC-O under the company's Health Canada research license in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical testing.